Studies have linked IL-6 with increasing the pathogenesis of the MM condition by preventing the MM cells from undergoing apoptosis, suggesting that targeting IL-6 could be an effective strategy for reducing tumorigenesis (Gadó et al., 2000). The gene discussed is IL6; the disease is Miyoshi myopathy.